Skip to main content
. 2016 Apr 26;7(23):34860–34880. doi: 10.18632/oncotarget.8992

Figure 3. Specific Trk pathway inhibitors reduce SK-ES-1 cell growth.

Figure 3

Cell proliferation, accessed by cell counting (n = 3), was reduced after 72-h treatment with 20 μM LY294002 (PI3K inhibitor; p < .05), UO 126 (MAPK inhibitor p < .05), or Gö 6983 (PLCγ/PKC inhibitor; p < .01) compared to controls.